Anti-Fibrinogen Beta Chain (FGB) Monoclonal Antibody Homo sapiens (Human) Protein, Antibody, Assaykit, Service

FG-B; Fibrinopeptide B; Fibrinogen Beta

No quotes Distributors
Overview
Properties
  • Ig Isotype IgG, Clone Number 6#
  • PurificationAntigen-specific affinity chromatography followed by Protein A affinity chromatography
  • LabelNone
  • Excitation Laser
  • Vol. per test
  • Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  • TraitsLiquid
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Anti-Fibrinogen Beta Chain (FGB) Monoclonal Antibody Packages (Simulation)
  • Anti-Fibrinogen Beta Chain (FGB) Monoclonal Antibody Packages (Simulation)
  • Anti-Fibrinogen Beta Chain (FGB) Monoclonal Antibody Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10µg/ml mouse Anti-human FGB Monoclonal Antibody (Catalog FAB215Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu01, green histogram), followed by 1µg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Usage

Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.

Storage

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

Giveaways

Citations

  • Compositions and Methods for Diagnosing Lung Cancery2016:0077095.html
  • Crystal structure of GAPDH of Streptococcus agalactiae and characterization of its interaction with extracellular matrix moleculesPubmed: 30553015
  • Nattokinase-heparin exhibits beneficial efficacy and safety—an optimal strategy for CKD patients on hemodialysisPubmed: 30788657

Recommend products